PharmiWeb.com - Global Pharma News & Resources

Reports - Press Releases

Date Title Company
18-Dec-2024 Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNA AccessWire
18-Dec-2024 NeoPredics Welcomes Todd Usen as Chairman of the Board AccessWire
18-Dec-2024 Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONA AccessWire
18-Dec-2024 The Naderi Center for Plastic Surgery and Dermatology Reveals Updated Website for Virginia and Maryland Patients AccessWire
18-Dec-2024 CBD Life Sciences Inc. (CBDL) Announces 3.5 Billion Share Reduction From the Authorization AccessWire
18-Dec-2024 Interactive Strength Inc. (Nasdaq:TRNR) Secures 162 Unit CLMBR Commitment and Signs Exclusive Distribution Agreement With Planet Fitness SAS for France AccessWire
17-Dec-2024 Osceola County Commission Approves Negotiations With Medical Device Company to Establish Presence at NeoCity AccessWire
17-Dec-2024 Onyx Ranked #1 for Client Satisfaction in FHIR-Based Prior Authorization Solutions AccessWire
17-Dec-2024 Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines AccessWire
17-Dec-2024 PillSafe Founders' Interview Featured on Bloomberg, Fox Business, and Nasdaq AccessWire
17-Dec-2024 Owen Mumford, Inc. Launches Injection Pen Training Video for Healthcare Professionals AccessWire
17-Dec-2024 Rehab.com Announces Dr. Sylvie Stacy as New Medical Officer AccessWire
17-Dec-2024 Theranexus Presents an Update of its Cash Position and Financing Horizon AccessWire
17-Dec-2024 Theranexus and Exeltis (Insud Pharma) Announce Licensing Agreement to Commercialize Theranexus Tx01 for Two Rare Neurological Disorders AccessWire
17-Dec-2024 Glidewell Opens Applications for 5th Annual Guiding Leaders Program AccessWire
17-Dec-2024 Cellev8 Nutrition Files Two Patents at US Trademark and Patent Office AccessWire
17-Dec-2024 Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment AccessWire
17-Dec-2024 Esteemed Harvard Medical School Professor Dr. Michael Gibson Appointed Chief Medical Advisor at Lexaria Bioscience AccessWire
17-Dec-2024 Proprietary Technology Addressing the Rx-to-OTC Switch Self-Care Market Valued at over $38 Billion annually AccessWire
17-Dec-2024 FDA Approves Orphan-Drug Designation for Jaguar Health’s Crofelemer for Treatment of Diarrhea in Cholera AccessWire